Overview
Nicholas Mark is an Intensive Care Medicine provider in Seattle, Washington. Dr. Mark is rated as an Experienced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Cannabinoid Hyperemesis Syndrome (CHS) and COVID-19.
His clinical research consists of co-authoring 17 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of COVID-19.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
925 Seneca St, Seattle, WA 98101
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Virginia Mason Medical Center
Carmen Mikacenic, MD, is a board-certified pulmonologist who specializes in interstitial lung disease including pulmonary fibrosis, lung complications of autoimmune diseases, sarcoidosis and acute respiratory distress syndrome.In her approach to patients, Dr. Mikacenic believes the evaluation and plan of care should be tailored to each individual. She enjoys helping patients with complex lung problems develop a good understanding of their disease so they can make informed, personalized decisions about their care.Dr. Mikacenic is a clinical associate professor in the Division of Pulmonary, Critical Care and Sleep Medicine at the University of Washington. She is a member of the American Thoracic Society and an associate member of Benaroya Research Institute. An expert in interstitial lung disease, Dr. Mikacenic recruits patients with these diseases for studies as part of her active research program at the institute.Away from work, Dr. Mikacenic enjoys soccer and baking. Dr. Mikacenic is rated as a Distinguished provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Acute Respiratory Distress Syndrome (ARDS), COVID-19, Acute Interstitial Pneumonia, Sarcoidosis, and Endoscopy.
Gme Office University Of Washington
Laura Evans is an Intensive Care Medicine provider in Seattle, Washington. Dr. Evans is rated as an Experienced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Severe Acute Respiratory Syndrome (SARS), COVID-19, Acute Respiratory Distress Syndrome (ARDS), and Pneumonia.
Gme Office University Of Washington
Reena Mehra is an Intensive Care Medicine provider in Seattle, Washington. Dr. Mehra is rated as a Distinguished provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Obstructive Sleep Apnea, Cerebral Hypoxia, Central Sleep Apnea, and Obesity Hypoventilation Syndrome (OHS).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cannabinoid Hyperemesis Syndrome (CHS)
- COVID-19Dr. Mark isExperienced. Learn about COVID-19.

